
Phillips 66 Ordered to Pay $800M to Propel Fuels Over Trade Secret Theft
Aug 01, 2025 01:18 am UTC| Business Law
U.S. oil refiner Phillips 66 (NYSE: PSX) has been ordered by a California state court to pay $800 million to biofuel producer Propel Fuels for misappropriating trade secrets to strengthen its renewable fuel operations. The...

Big Tech’s AI Spending Surge Fuels Revenue Growth and Investor Confidence
Aug 01, 2025 01:14 am UTC| Business Technology
Tech giants Microsoft (NASDAQ:MSFT), Meta (NASDAQ:META), Amazon (NASDAQ:AMZN), and Alphabet (NASDAQ:GOOGL) are ramping up artificial intelligence investments as demand for AI-driven services accelerates. In the April-June...

JD.com Expands into Europe with $2.5 Billion Ceconomy Acquisition
Jul 31, 2025 03:11 am UTC| Business
JD.com, one of Chinas largest e-commerce companies, is acquiring German electronics retailer Ceconomy in a deal valued at 2.2 billion ($2.5 billion). The acquisition will give JD.com control of Ceconomys popular MediaMarkt...

OpenAI Revenue Surges to $12 Billion Amid AI Boom
Jul 31, 2025 01:58 am UTC| Technology Business
OpenAI, the creator of ChatGPT, has nearly doubled its revenue in the first seven months of 2025, reaching an annualized figure of $12 billion, according to a report by The Information. The rapid growth highlights the...

Hyundai, Kia Shares Drop as U.S. Imposes 15% Tariff on South Korean Auto Imports
Jul 31, 2025 01:54 am UTC| Business Economy
Shares of South Korean automakers Hyundai Motor (OTC: HYMTF) and Kia Corp declined on Thursday following U.S. President Donald Trumps announcement of a 15% tariff on imports from South Korea, including automobiles, under a...

SpaceX’s Bahamas Rocket Deal Stalled After Starship Explosion
Jul 31, 2025 01:47 am UTC| Technology Business
SpaceXs negotiations with the Bahamas to allow Falcon 9 rocket boosters to land in the island nation have been delayed following the mid-flight explosion of its Starship rocket in March, which scattered debris across...

AbbVie Reportedly in Talks to Acquire Gilgamesh Pharmaceuticals for $1 Billion
Jul 31, 2025 01:40 am UTC| Business
AbbVie Inc. (NYSE: ABBV) is reportedly negotiating the acquisition of Gilgamesh Pharmaceuticals, a privately held mental health therapeutics company, in a deal valued at around $1 billion, according to Bloomberg. The...